126 related articles for article (PubMed ID: 15601306)
1. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
Nascimento I; Schaer R; Lemaire D; Freire S; Paule B; Carvalho S; Meyer R; Schaer-Barbosa H
APMIS; 2004 Sep; 112(9):585-7. PubMed ID: 15601306
[TBL] [Abstract][Full Text] [Related]
2. [Role of c-c chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.
Shu J; Sun G; Liu H; Liu J
Acta Oncol; 2007; 46(7):1004-11. PubMed ID: 17917830
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
7. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
[TBL] [Abstract][Full Text] [Related]
8. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
[TBL] [Abstract][Full Text] [Related]
9. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
10. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
[TBL] [Abstract][Full Text] [Related]
11. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of vascular endothelial growth factor in malignant ascites.
Zhan N; Dong WG; Wang J
Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
[TBL] [Abstract][Full Text] [Related]
13. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
14. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
15. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
[TBL] [Abstract][Full Text] [Related]
17. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
18. [Vascular endothelial growth factor and two types of its receptors in breast cancer].
Shcherbakov AM; Gershteĭn ES; Anurova OA; Kushlinskiĭ NE
Vopr Onkol; 2005; 51(3):317-21. PubMed ID: 16279095
[TBL] [Abstract][Full Text] [Related]
19. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
Hotz HG; Hines OJ; Masood R; Hotz B; Foitzik T; Buhr HJ; Gill PS; Reber HA
Surgery; 2005 Feb; 137(2):192-9. PubMed ID: 15674201
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.
Peyromaure M; Badoual C; Camparo P; Grabar S; Goulvestre C; Fulla Y; Vieillefond A; Mao K; Dinh-Xuan AT
Oncol Rep; 2007 Jul; 18(1):145-9. PubMed ID: 17549360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
